Our preliminary bioinformatics from TCGA and CGGA mining unerringly exhibit that GRPEL2 gene expression correlates with WHO tumor grades (p < 0.001), IDH mutation status (p < 0.001), and overall survival (p < 0.001), and highly correlated with TERT expression in gliomas. This evidence concerns the gene GRPEL2 and central nervous system cancer.